glabridin has been researched along with Invasiveness, Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MK; Chiou, HL; Hsieh, MJ; Lin, CW; Yang, SF | 1 |
1 other study(ies) available for glabridin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Isoflavones; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Phenols; Phosphorylation; Signal Transduction; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transcription, Genetic; Transfection; Xenograft Model Antitumor Assays | 2014 |